Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A review published in 2025 in the Journal of Crohns and Colitis suggests that GLP-1 medications have both metabolic and anti-inflammatory benefits for people with IBD, with early studies linking them to improved outcomes like fewer hospitalizations
Seek urgent medical attention for persistent vomiting, severe abdominal pain radiating to the back, signs of dehydration, or symptoms suggesting pancreatitis or gallbladder complications
Similarly, a 2024 study published in the Journal of the American Medical Association analyzed data from 16,827 patients and found that those prescribed semaglutide had a significantly higher risk of developing NAION compared to those on non-GLP-1 medications
There is limited evidence supporting this approach, and it should be reserved for severe, refractory cases under gastroenterology specialist guidance
If constipation improves, those were contributing factors
because B vitamins are essential for a wide range of functions in the body
US$ 24.10
US$ 21.81
US$ 26.18
US$ 21.02
US$ 19.98
US$ 25.46
US$ 26.35
US$ 22.98
